Explore the benefits and considerations of adjuvant immunotherapy in the treatment of resectable non-small cell lung cancer (NSCLC). Review the latest clinical trials, including IMpower 010 and Checkmate 816, and learn about the potential role of neoadjuvant therapy.

11 views • 28 slides

POSNOC (Positive Sentinel Node) and ATNEC trials are investigating the effectiveness of axillary treatment in women with early-stage breast cancer having metastases in one or two sentinel nodes. Led by Chief Investigator Amit Goyal in the UK, this randomized controlled trial compares adjuvant therap

1 views • 21 slides

In the management of rectal cancer, the debate between surgical resection and organ preservation after neoadjuvant chemoradiotherapy is ongoing. While surgical resection is highly effective, the watch-and-wait strategy offers benefits such as avoiding permanent stomas and improving quality of life.

1 views • 14 slides